Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Rose 24% in First Half of 2022

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 176.2 million yuan in the first half of 2022, up 24% year-on-year.

Meanwhile, the company posted 388.9 million yuan in revenue, up 11.9% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 111.7 million yuan in total liabilities, with a liability-to-asset ratio of 5.6%.